Page 215 - Read Online
P. 215

are often detected  in cervical  cancers as well as other   although HPV may play a role in vulvar cancer, this
            epithelial tumors.                                 association is not clear.

            The underlying mechanism of the progression from CIN1   BREAST CANCER
            through  CIN2, CIN3 and  eventually  cancer  is  not  well
            established, it may be due to the early integration events   Several epidemiological studies reported HPV detection in
            in CIN1 or due to deregulation of viral gene expression.   breast cancer samples. [105-109]  Nevertheless the role of HPV
            It is also possible that the initial  deregulation  leads to   in  breast  carcinogenesis  is by far  not  certain  and  further
            instability  of chromosomes and causes integration.  It is   randomized  control  trials  are required  to establish  the
            believed that the integration arises in high grade lesions,   definite role of HPV in breast cancer development.
            such as CIN2 and CIN3 and the deregulation of E6 and E7
            expression may increase or remain at a constitute level. [92,93]   HEAD AND NECK CARCINOMAS
            In this scheme, flat warts can be resembled in CIN1 lesions,
            however the proliferation level of the cell is lower in the   Head and neck carcinomas involve a wide range of tumors
                                                                                                        [110]
            basal and parabasal layers.  Increased expression levels   and is one of the most common cancers worldwide.   The
                                  [13]
            of E6  and E7 in high-risk HPV type  infections  causes   prevalence of HPV DNA in head and neck cancers depends
                                                                                                   [104]
            CIN2+ phenotypes. This phenotype leads genetic changes   on the cancer site, geography and ethnicity.   The most
            that  contribute  to cancer  progression.  These  suggest that   consistent prevalence of HPV infection is the oropharyngeal
                                                               cancers with an association  of 35-50% in developed
            low expression levels of E6 and E7 does not affect the
            function of the cellular targets in CIN1 and therefore does   cancers, whereas the HPV is detected  in approximately
                                                                                                 [52,84]
            not contribute to cancer progression. In CIN2/ CIN3+, the   5-15% within  the  rest  of the  oral  cavity.  The  overall
            viral deregulation assists the viral episome into the host cell   risk factors for head and neck carcinomas include tobacco
            chromosome. This may  further cause  deregulation  of E6   smoking and alcohol consumption.
            and E7 expression. In clinical vaccine trials it was shown   The first cases of HPV relationships with oral cell squamous
            that young women can have CIN2+ soon after infection [94-97]   cell carcinomas were reported in 2008 for lingual cancer,
            for these cases, it is possible that deregulation of the gene   tonsil cancer and oropharyngeal cancers. [111,112]  Overall the
            expression is due to cell signaling changes  or epigenetic   prevalence of these cancers are higher in men compared to
                                              [98]
            modifications, such as viral DNA methylation. [99]  women. [113]  Oropharyngeal carcinomas (OPCs) are the most
                                                               studied and the most characterised type of head and neck
            An important  step has been  taken  towards prevention  of   carcinomas. In the last decade the incidence of HPV related
            HPV induced cervical  cancers  with the use of vaccines   OPCs have  doubled  in  number of patients  and  therefore
            against HPV. However, due to various reasons, including the   more attention  has drawn to these cancer  types. [114]  HPV
            unavailability of the vaccines in certain regions of the world   positive  oropharyngeal  cancers are  mainly  associated
            or the high costs of the vaccines, the wide application of   with oral sex and rare p53 mutation. [115]  Interestingly HPV
            the vaccines is not available. Therefore, in case of cervical   infection was shown to improve the prognosis of OPC with
            cancer development, early detection strategies and treatment   better survival is reported in HPV positive OPCs [116]  and
            play a vital role to prevent any deaths. The treatment for the   therefore these patients may have a chance to benefit from
            early cervical cancers is usually performed by conisation   a less intense  treatment  strategy. [117]  Chemotherapy  using
            or radical hysterectomy. For the more advanced tumors,   paclitaxel, cisplatin on centuximab; followed by concurrent
            cisplatin based chemo-radiotherapy is preferred that results   radiation has been used in treatment of OPC patiens. [118]  With
            in 65-80% survival rates. Surgical  excisions are usually   the increasing number of HPV associated OPC patients, the
            the standard for the HPV associated anogenital lesions. [100]    use of antiviral and immunotherapeutic strategies show an
            The treatment strategy for CIN is to eliminate the abnormal   improved  outcome.   Although  HPV related  OPC have
                                                                               [42]
            HPV infected precancerous cells and maintain the cervical   increased through the years, the HPV negative OPCs still
            integrity. One of the most commonly used treatments for   account for the majority of the OPC patients.
            CIN involves  loop  electrosurgical  excision  procedure,
            electrofulgaration and cryotherapy. [101]          The HPVs, mostly HPV16 and HPV33, were detected
                                                               in quarter of the patients with invasive laryngeal cancers
            The other lower genital cancers include vulvar and vaginal   and are predominantly detected in women compared to
            cancers. Majority of the vulvar and vaginal cancers are   men. [119-121]  HPV is also associated with potential malignant
            squamous cell carcinomas.  In majority of the cancers of   disorders, such as erythroplakia, oral leukoplakia and
                                 [57]
            the vagina HPV DNA is detected; approximately half of the   oral lichen planus. [122]  Erythroplakia has the highest
            vaginal cancers are caused by HPV16 (54%) followed by   risk of malignant transformation. Half of the cases with
            HPV18 (8%).  Similarly, HPV DNA is detected in most   erythroplakias alone is associated with HPV infection [123]
                       [57]
            of the vulvar intraepithelial neoplasia, however only half of   and  the    frequency  of  the  HPV  detection  influences  the
            these neoplasias causes cancer. HPV16 is associated with   severity of the lesions. In one study the HPV prevalence
            32% and HPV18 with 4% of the cases. [57,102-104]  Therefore,   was 32.8% in oral lichen planus, 40.9% in oral leukoplakia


                        Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ June 15, 2016 ¦           205
   210   211   212   213   214   215   216   217   218   219   220